Literature DB >> 33535641

The Diverse Calpain Family in Trypanosomatidae: Functional Proteins Devoid of Proteolytic Activity?

Vítor Ennes-Vidal1, Marta Helena Branquinha2, André Luis Souza Dos Santos2,3, Claudia Masini d'Avila-Levy1.   

Abstract

Calpains are calcium-dependent cysteine peptidases that were originally described in mammals and, thereafter, their homologues were identified in almost all known living organisms. The deregulated activity of these peptidases is associated with several pathologies and, consequently, huge efforts have been made to identify selective inhibitors. Trypanosomatids, responsible for life-threatening human diseases, possess a large and diverse family of calpain sequences in their genomes. Considering that the current therapy to treat trypanosomatid diseases is limited to a handful of drugs that suffer from unacceptable toxicity, tough administration routes, like parenteral, and increasing treatment failures, a repurposed approach with calpain inhibitors could be a shortcut to successful chemotherapy. However, there is a general lack of knowledge about calpain functions in these parasites and, currently, the proteolytic activity of these proteins is still an open question. Here, we highlight the current research and perspectives on trypanosomatid calpains, overview calpain description in these organisms, and explore the potential of targeting the calpain system as a therapeutic strategy. This review gathers the current knowledge about this fascinating family of peptidases as well as insights into the puzzle: are we unable to measure calpain activity in trypanosomatids, or are the functions of these proteins devoid of proteolytic activity in these parasites?

Entities:  

Keywords:  Leishmania; Trypanosoma; chemotherapy; cysteine peptidase

Year:  2021        PMID: 33535641      PMCID: PMC7912814          DOI: 10.3390/cells10020299

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  44 in total

1.  Effects of the calpain inhibitor MDL28170 on the clinically relevant forms of Trypanosoma cruzi in vitro.

Authors:  Vítor Ennes-Vidal; Rubem F S Menna-Barreto; André L S Santos; Marta H Branquinha; Claudia M d'Avila-Levy
Journal:  J Antimicrob Chemother       Date:  2010-05-10       Impact factor: 5.790

2.  Calcium-dependent proteolytic activity of a cysteine protease caldonopain is detected during Leishmania infection.

Authors:  Runu Dey; Jharna Bhattacharya; Salil C Datta
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

3.  Protease expression by microorganisms and its relevance to crucial physiological/pathological events.

Authors:  André Luis Souza Dos Santos
Journal:  World J Biol Chem       Date:  2011-03-26

4.  Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity.

Authors:  A Rami; D Ferger; J Krieglstein
Journal:  Neurosci Res       Date:  1997-01       Impact factor: 3.304

5.  Susceptibility of promastigotes and intracellular amastigotes from distinct Leishmania species to the calpain inhibitor MDL28170.

Authors:  Pedro Soares de Sousa Araújo; Simone Santiago Carvalho de Oliveira; Claudia Masini d'Avila-Levy; André Luis Souza Dos Santos; Marta Helena Branquinha
Journal:  Parasitol Res       Date:  2018-05-04       Impact factor: 2.289

6.  Calcium dependent thiol protease caldonopain and its specific endogenous inhibitor in Leishmania donovani.

Authors:  J Bhattacharya; R Dey; S C Datta
Journal:  Mol Cell Biochem       Date:  1993-09-08       Impact factor: 3.396

Review 7.  Evolution of parasitism in kinetoplastid flagellates.

Authors:  Julius Lukeš; Tomáš Skalický; Jiří Týč; Jan Votýpka; Vyacheslav Yurchenko
Journal:  Mol Biochem Parasitol       Date:  2014-06-02       Impact factor: 1.759

8.  Calpains of Leishmania braziliensis: genome analysis, differential expression, and functional analysis.

Authors:  Vítor Ennes-Vidal; Bianca da Silva Vitório; Rubem Figueiredo Sadok Menna-Barreto; André Nóbrega Pitaluga; Silvia Amaral Gonçalves-da-Silva; Marta Helena Branquinha; André Luis Souza Santos; Claudia Masini d'Avila-Levy
Journal:  Mem Inst Oswaldo Cruz       Date:  2019-09-23       Impact factor: 2.743

Review 9.  Calpains: potential targets for alternative chemotherapeutic intervention against human pathogenic trypanosomatids.

Authors:  M H Branquinha; F A Marinho; L S Sangenito; S S C Oliveira; K C Goncalves; V Ennes-Vidal; C M d'Avila-Levy; A L S Santos
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 10.  Exploring the environmental diversity of kinetoplastid flagellates in the high-throughput DNA sequencing era.

Authors:  Claudia Masini d'Avila-Levy; Carolina Boucinha; Alexei Kostygov; Helena Lúcia Carneiro Santos; Karina Alessandra Morelli; Anastasiia Grybchuk-Ieremenko; Linda Duval; Jan Votýpka; Vyacheslav Yurchenko; Philippe Grellier; Julius Lukeš
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-11-24       Impact factor: 2.743

View more
  3 in total

1.  Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors.

Authors:  Vítor Ennes-Vidal; André Luis Souza Dos Santos; Marta Helena Branquinha; Claudia Masini d'Avila-Levy
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-03-25       Impact factor: 2.743

2.  Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B.

Authors:  Marta H Branquinha; Pedro S S Araújo; Simone S C Oliveira; Leandro S Sangenito; Diego S Gonçalves; Sérgio H Seabra; Claudia M d'Avila-Levy; André L S Santos
Journal:  Trop Med Infect Dis       Date:  2022-02-16

Review 3.  A Comprehensive Investigation Regarding the Differentiation of the Procurable COVID-19 Vaccines.

Authors:  Surojit Banerjee; Debadri Banerjee; Anupama Singh; Vikas Anand Saharan
Journal:  AAPS PharmSciTech       Date:  2022-03-21       Impact factor: 4.026

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.